Results 121 to 130 of about 257,683 (336)
This review highlights the complex roles of cellular senescence in cancer progression and suppression, discusses the mechanisms and regulatory pathways involved, and evaluates the efficacy of the “One‐Two punch” sequential treatment approach while addressing emerging challenges in this novel therapeutic strategy.
Qiuming Pan+12 more
wiley +1 more source
Abstract Background Diffuse large B‐cell lymphoma (DLBCL) is the most common subtype of aggressive non‐Hodgkin's lymphoma with distinct clinical and molecular heterogeneity. DLBCL that arises in extranodal organs is particularly linked to poor prognosis. This study aimed to determine the clinical and molecular characteristics of extranodal involvement (
Si‐Yuan Chen+46 more
wiley +1 more source
Clinical evaluation of a new alkylating agent: Cytoxan (cyclophosphamide) [PDF]
Peter R. Coggins+2 more
openalex +1 more source
Abstract Background The standard adjuvant chemotherapy for early‐stage, high‐risk breast cancer includes anthracyclines and taxanes. While anthracycline‐based regimens have proven effective in human epidermal growth factor receptor 2 (HER2)‐positive breast cancer, their efficacy may be reduced in HER2‐negative patients due to the lack of co ...
Yu Song+6 more
wiley +1 more source
THE INDUCTION OF GRAFT VERSUS HOST DISEASE IN MICE TREATED WITH CYCLOPHOSPHAMIDE [PDF]
Albert H. Owens, George W. Santos
openalex +1 more source
The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide
S. Viaud+32 more
semanticscholar +1 more source
Mm. To study effects of cyclophosphamide (CP) on duration of remission in chronic glomerulonephritis (CGN) with nephrotic syndrome (NS). Material and methods.
V L Duman, L I Shkerina
doaj
Cyclophosphamide in Hodgkin's Disease and Related Disorders [PDF]
J. Q. Matthias+2 more
openalex +1 more source
Cyclophosphamide and pigmentation. [PDF]
C.B.S. Wood, B M Harrison
openaire +3 more sources